Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 15 of 15 for “"Bivalent Ligand"”.
-
Bivalent Ligand MMG22 Reduces Bone Cancer Pain without Tolerance or Sedation
… therapeutic approaches are needed. MMG22 is a bivalent ligand containing MOR agonist and mGluR5 antagonist pharmacophores joined by a 22-atom spacer. MMG22 exhibited extraordinary analgesia following intrathecal administration in a mouse model of bone cancer pain. Here, we assessed the …
-
MMG22: A Novel Bivalent Ligand for the Treatment of Neuropathic Pain
… analgesia have been well established. MMG22 is a bivalent ligand containing MOR agonist (oxymorphamine) and mGluR5 antagonist (MPEP) pharmacophores tethered by a 22-atom linker. MMG22 has been shown to produce potent analgesia in several models of chronic inflammatory and neuropathic pain. This …
-
Linker Functionalization of a Bivalent Ligand for the Study of the 5-HT2AR/ 5-HT2CR Heterodimer
… and cue reactivity has been reported. A bivalent ligand containing these two pharmacophores, linked by a polyethylene glycol chain and a triazole, has been developed. In this thesis, attempts to functionalize the linker portion of the bivalent ligand for the addition of a fluorophore are …
-
Radiolabeled bivalent peptide ligands for prostate cancer imaging
… This dissertation is focused on the so-called bivalent ligand, a radiotracer that has two types of targeting motifs for two different biomarkers. Several bivalent ligands composed of different targeting vectors are discussed. The first bivalent ligand, [DUPA-6-Ahx-K-5-Ava-BBN(7-14)NH2], for …
-
Design, Synthesis, and Biological Evaluation of Novel Hetero-Bivalent Ligands Targeting Kinases
Hetero-bivalent ligands consist of two copies of monomers that are connected through a linker. They show improved affinity towards their target through an avidity effect and can also enhance specificity, as part of the binding pocket may be absent in a similar target. This strategy was successful …
-
DEVELOPMENT OF ANTAGONISTS TARGETING CHEMOKINE RECEPTOR CCR5 AND THE CHEMOKINE RECEPTOR CCR5 – MU OPIOID RECEPTOR HETERODIMER
… prostate cancer cell lines. In addition, a bivalent ligand containing both a mu opioid receptor (MOR) and a CCR5 antagonist pharmacophore was designed and synthesized in order to study the pharmacological profile of the putative CCR5-MOR heterodimer and its relation with NeuroAIDS. The …
-
Investigating the Role of Serotonin 2A and 2C Receptors in Neurobiology
… and the possibility of GPCR oligomers existence, bivalent ligands tethering M100907 and WAY163909 through click reaction have been developed. The proper site to tether the linker on M100907 molecule has been reported. In this dissertation, we reported various WAY163909 analogues to determine the …
-
Advances in myotonic dystrophy type 1 drug discovery through design of novel ligands and mechanism establishment
… (Chapter 2) and a small library of dimeric ligands (Chapter 3) leading to an optimized bivalent ligand. These novel ligands target CUGexp RNA and are able to inhibit the CUGexp⋅MBNL1 interaction in cells that model DM1. In a DM1 cell model these ligands were found to disperse CUGexp …
-
Conformational entropy from molecular simulations
… to conformational transitions and protein- ligand binding. (b) A model to describe the enhancement of the binding affinity for a bivalent ligand tethered with a polymer spacer was expounded. The novelty of the model consists in the inclusion of spacer-receptor interactions. (a) Balanced and …
-
Development of Bivalent Ligands Targeting the Putative CCR5-MOR Heterodimer
… that destroy primary neuronal cells.15 A bivalent ligand targeting the putative CCR5-MOR heterodimer was proposed to probe the interaction between the two proteins and act as a potential therapeutic ligand to combat neuroAIDS.16 A bivalent ligand attaching maraviroc, a CCR5 antagonist, …
-
Bivalent Ligands as Pharmacological Probes for The Melanocortin Receptors: The Bivalent Advantage
… the functional effects of melanocortin bivalent ligands both in vitro and in vivo. In Chapter 3 and Chapter 4, traditional homobivalent approaches are utilized. The synthesis and in vitro evaluation of homobivalent ligands are discussed in Chapter 3. Lead ligands (CJL-1-87 and CJL-1-31) …
-
Selective Control of Protein Kinases and Phosphatases
… the potency and possible selectivity imparted by bivalent inhibitors and developed an in vitro selection approach to discover bivalent ligands. The strategy involves the use of an ATP-competitive small molecule warhead and a library of cyclic peptides displayed on phage that interact with the …
-
Design and Synthesis of Novel Benzodiazepines
Bivalent drug design is an efficient strategy for increasing potency and selectivity of many drugs. We devised a strategy to prepare agonist-benzodiazepine heterodimers that could simultaneously bind to agonist and BZD sites of the GABAAR. We synthesized a benzodiazepine-MPEG model compound that …
-
New alkylpiperazines as 5-HT7R ligands
… sono state identificate differenti classi di ligandi ad alta affinità ma non selettivi. Nell’ultima decade, notevoli sforzi sono stati fatti per scoprire nuovi agenti selettivi e i derivati long-chain aril-piperazininici rappresentano una fra le classi più promettenti, in quanto mostrano …
-
The compatibility of modified nucleic acids with enzymatic copying and ligand selection
Modified nucleic acids have important applications in molecular biology, genetics and genomics. Here I report a series of modified 5-aminomethyl-deoxyuridine (5-AM-dU) analogues with different functional groups on the 5-position of the pyrimidine ring. These modified 5-AM-dU nucleotides were …